Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 63.42M P/E - EPS this Y 84.00% Ern Qtrly Grth -
Income -7.2M Forward P/E -2.45 EPS next Y -103.00% 50D Avg Chg -19.00%
Sales 2.84M PEG - EPS past 5Y - 200D Avg Chg -26.00%
Dividend N/A Price/Book 12.67 EPS next 5Y - 52W High Chg -48.00%
Recommedations 2.20 Quick Ratio 1.19 Shares Outstanding 8.55M 52W Low Chg 4.00%
Insider Own 1.62% ROA -71.42% Shares Float 8.41M Beta 1.39
Inst Own 7.10% ROE - Shares Shorted/Prior 35.40K/32.72K Price 0.74
Gross Margin - Profit Margin -253.60% Avg. Volume 273,682 Target Price 20.33
Oper. Margin -32,799.12% Earnings Date Nov 7 Volume 380,742 Change 0.68%
About Dare Bioscience, Inc.

Daré Bioscience, Inc., a biopharmaceutical company, identifies, develops, and markets products for women's health in the United States. It develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health. The company offers XACIATO for the treatment of bacterial vaginosis in female patients 12 years of age and older. It is developing Ovaprene, a hormone-free, monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia on demand for the treatment of female sexual arousal disorder; DARE-HRT1 to treat moderate to-severe vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of moderate-to-severe dyspareunia or pain during sexual intercourse; and DARE-CIN to treat cervical intraepithelial neoplasia and other human papillomavirus related pathologies. The company is also developing DARE-PDM1 for the treatment of primary dysmenorrhea; DARE-204 and DARE-214, an injectable formulations contraception of etonogestrel designed to provide contraception over 6-month and 12-month periods; DARE-FRT1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB1 for the prevention of preterm birth. In addition, it is developing DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design that controlled contraceptive option; DARE-LBT, a novel hydrogel formulation for vaginal delivery of live biotherapeutics to support vaginal health; DARE-GML, a multi-target antimicrobial agent; DARE-RH1, a novel approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; and DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein. Daré Bioscience, Inc. is headquartered in San Diego, California.

Dare Bioscience, Inc. News
11/15/24 Q3 2024 Dare Bioscience Inc Earnings Call
11/15/24 Dare Bioscience Inc (DARE) Q3 2024 Earnings Call Highlights: Strategic Advancements and ...
11/14/24 Dare Bioscience, Inc. (DARE) Reports Q3 Loss, Lags Revenue Estimates
11/14/24 Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company Update
11/13/24 Daré Bioscience Announces Grant to Support Development of a Novel Non-Hormonal Contraceptive Candidate and Expansion of Ovaprene® Pivotal Study Clinical Trial Sites
11/07/24 Dare Bioscience (DARE) Upgraded to Buy: Here's What You Should Know
11/07/24 Daré Bioscience to Host Third Quarter 2024 Financial Results and Company Update Conference Call and Webcast on November 14, 2024
10/30/24 Is Bavarian Nordic (BVNRY) Stock Outpacing Its Medical Peers This Year?
10/23/24 Daré Bioscience Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health
10/21/24 Daré Bioscience Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital Fund, LLC
08/26/24 Daré Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Safety Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6%
08/13/24 Daré Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6%
08/12/24 Dare Bioscience, Inc. (DARE) Q2 Earnings Top Estimates
08/12/24 Daré Bioscience Reports Second Quarter 2024 Financial Results and Provides Company Update
08/05/24 Daré Bioscience to Host Second Quarter 2024 Financial Results and Company Update Conference Call and Webcast on August 12, 2024
07/19/24 Daré Bioscience Regains Compliance with Nasdaq Minimum Bid Price Rule
06/27/24 Daré Bioscience Announces Reverse Stock Split
07:00 AM Daré Bioscience Announces Publication in Obstetrics & Gynecology of Phase 2b Study Efficacy Results of Topical Sildenafil Cream, 3.6% for the Treatment of Female Sexual Arousal Disorder
05/15/24 Q1 2024 Dare Bioscience Inc Earnings Call
05/15/24 Dare Bioscience Inc (DARE) (Q1 2024) Earnings Call Transcript Highlights: Strategic Moves Amid ...
DARE Chatroom

User Image F_The_short Posted - 1 day ago

$DARE 😡😡😡😡

User Image benandemmiboo Posted - 2 days ago

$DARE https://ir.darebioscience.com/static-files/53480b55-0528-41f0-8692-c7c7bc41dbdf

User Image Guy592 Posted - 2 days ago

$DARE what a dumb scumbag pumper. Anything to make his boss feel good. Look at the meaningful post. POS paid pumper. No life.

User Image BiotechJedi1728 Posted - 2 days ago

$DARE This looks like a team that just won a lot of non-dilutive funding and cut a deal for Sildenafil 👀 You can't hide happiness and contentment. Legit and it can be infectious just like success. https://x.com/darebioscience/status/1860055111957119370?s=12

User Image albion Posted - 2 days ago

$DARE the good thing about the RFK debacle is that it gave biotech a stress test showing prices with a hostile administration, whoever is appointed to HHS hopefully isn't another worm addled moron

User Image F_The_short Posted - 2 days ago

$DARE Criminal manipulation has to stop 😡😡😡

User Image BiotechJedi1728 Posted - 2 days ago

$DARE RFK Jr. mourning is over. Biotech surging today. Back above $4. LFG.

User Image Guy592 Posted - 2 days ago

$DARE 1.5 hours in and zero volume. sheesh

User Image BiotechJedi1728 Posted - 2 days ago

$DARE LARC-1 More Gates funding soon. https://www.linkedin.com/posts/dare-bioscience_while-the-availability-of-effective-contraceptive-activity-7265396820455895044-sWpB?utm_source=share&utm_medium=member_ios

User Image petertradebull Posted - 3 days ago

$DARE what’s wrong with this? Is buyout on a horizon? 🚀🚀🚀

User Image F_The_short Posted - 4 days ago

$DARE Not selling you fouking shorts 🖕🖕🖕🖕🖕🖕😡😡😡😡

User Image petertradebull Posted - 4 days ago

$DARE my PT $30 🚀🚀🚀

User Image Guy592 Posted - 4 days ago

$DARE currently sitting at $.265 pre reverse split. Sad.

User Image F_The_short Posted - 5 days ago

$DARE 😡😡😡😡😡😡Not Foken selling 😡😡😡

User Image YoImCrappy Posted - 5 days ago

$DARE trash

User Image TheArsenal Posted - 5 days ago

$DARE Biofraud buying…$2’s incoming

User Image BiotechJedi1728 Posted - 5 days ago

$DARE Buying more this week to get average even lower. Might be able to get it sub-$6. Crypto is ripping and think it is time to take some profit and reinvest it.

User Image ThreeYearPlan Posted - 6 days ago

$DARE for the record, of we get back to pre reverse split prices ($0.30-$0.40) I'm 💯 back in...

User Image petertradebull Posted - 6 days ago

$DARE still bullish 🚀🚀🚀

User Image Guy592 Posted - 1 week ago

$DARE They walked her up slowly from about $3.20 to $4.40 in about 10 days and took her down steeply in 3 days. Why? 20 million funding received. They gains and losses canceled out. Next.

User Image Guy592 Posted - 1 week ago

$DARE Green EOD and shock us all 😆

User Image albion Posted - 1 week ago

$DARE healthcare stocks down on Trump's RFK pick all those who own Biotech or EV stocks who voted for Trump "the only thing worse in life than not getting what you want is getting what you want" Oscar Wild

User Image ElysiumAnalytics Posted - 1 week ago

$DARE At this point yelling at Sabrina on her X account is more than justified… She should have harsh words thrown her way after legitimately losing her investors millions of dollars and running the company into the ground, and no accountability…

User Image F_The_short Posted - 1 week ago

$DARE Not fucking selling 😡😡😡😡😡🖕🖕🖕

User Image Investingdude Posted - 1 week ago

$DARE damn i started having hopes again but these last three days have been brutal

User Image Guy592 Posted - 1 week ago

$DARE

User Image Guy592 Posted - 1 week ago

$DARE notice the pattern of the pumper. See comments. Coincidence?

User Image petertradebull Posted - 1 week ago

$DARE when buyout? 🚀🚀🚀

User Image Green_Party Posted - 1 week ago

$DARE In case it matters to anyone: - I'm not RayRay. We have two very different styles. But I do hope he's doing well, whereever he is. - I've been here since 2021, I just post infrequently. - I appreciate input that's grounded and based on people's expertise and analysis. I don't have direct experience in biotech/finance, so people like Bio and Travis offer great perspectives. Healthy disagreement is helpful. - I don't appreciate people who make a lot of baseless personal attacks or just pump/bash without basis for the heck of it. I block those people, and I suggest everyone else do the same.

User Image Guy592 Posted - 1 week ago

$DARE there he is. Relentless scumbag. Hiding and posting, POS

Analyst Ratings
Jones Trading Buy Aug 16, 24
Maxim Group Hold Aug 14, 24
HC Wainwright & Co. Buy May 15, 24
Brookline Capital Buy May 15, 24
HC Wainwright & Co. Buy May 1, 24
Brookline Capital Hold Apr 17, 24
HC Wainwright & Co. Buy Apr 1, 24
HC Wainwright & Co. Buy Nov 10, 23
HC Wainwright & Co. Buy Aug 11, 23